{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T14:34:47Z","timestamp":1769524487099,"version":"3.49.0"},"reference-count":102,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T00:00:00Z","timestamp":1517270400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T00:00:00Z","timestamp":1517270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Clin Pract"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1111\/ijcp.13052","type":"journal-article","created":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T15:52:13Z","timestamp":1517327533000},"page":"e13052","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Evidence in support of hyperkalaemia management strategies: A systematic literature review"],"prefix":"10.1155","volume":"72","author":[{"given":"Eirini","family":"Palaka","sequence":"first","affiliation":[{"name":"AstraZeneca Ltd; Cambridge UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saoirse","family":"Leonard","sequence":"additional","affiliation":[{"name":"Costello Medical; Cambridge UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Buchanan-Hughes","sequence":"additional","affiliation":[{"name":"Costello Medical; Cambridge UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5001-7981","authenticated-orcid":false,"given":"Anna","family":"Bobrowska","sequence":"additional","affiliation":[{"name":"Costello Medical; Cambridge UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryony","family":"Langford","sequence":"additional","affiliation":[{"name":"Costello Medical; Cambridge UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Grandy","sequence":"additional","affiliation":[{"name":"AstraZeneca; Gaithersburg USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,1,30]]},"reference":[{"key":"10.1111\/ijcp.13052-BIB0001|ijcp13052-cit-0001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/CE.S129555","article-title":"Clinical utility of patiromer, sodium zirconium cyclosilicate, and sodium polystyrene sulfonate for the treatment of hyperkalemia: An evidence-based review","volume":"12","author":"Beccari","year":"2017","journal-title":"Core Evidence"},{"key":"10.1111\/ijcp.13052-BIB0002|ijcp13052-cit-0002","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00467-010-1699-3","article-title":"Pathogenesis, diagnosis and management of hyperkalemia","volume":"26","author":"Lehnhardt","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/ijcp.13052-BIB0003|ijcp13052-cit-0003","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/archinternmed.2009.132","article-title":"The frequency of hyperkalemia and its significance in chronic kidney disease","volume":"169","author":"Einhorn","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1111\/ijcp.13052-BIB0004|ijcp13052-cit-0004","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajem.2010.08.029","article-title":"Life-threatening hyperkalemia from nutritional supplements: Uncommon or undiagnosed?","volume":"29","author":"John","year":"2011","journal-title":"Am J Emerg Med"},{"key":"10.1111\/ijcp.13052-BIB0005|ijcp13052-cit-0005","unstructured":"UK Renal Association Clinical Practice Guidelines. Treatment of Acute Hyperkalaemia in Adults"},{"key":"10.1111\/ijcp.13052-BIB0006|ijcp13052-cit-0006","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1681\/ASN.V981535","article-title":"Hyperkalemia: A potential silent killer","volume":"9","author":"Weiner","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ijcp.13052-BIB0007|ijcp13052-cit-0007","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijcard.2016.04.127","article-title":"New approaches to hyperkalemia in patients with indications for renin angiotensin aldosterone inhibitors: Considerations for trial design and regulatory approval","volume":"216","author":"Zannad","year":"2016","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1111\/ijcp.13052-BIB0008|ijcp13052-cit-0008","doi-asserted-by":"crossref","first-page":"A43","DOI":"10.1053\/j.ajkd.2016.03.107","article-title":"Strategy for improved blood pressure (BP) control in resistant hypertension (RH) with diabetic kidney disease (DKD)","volume":"67","author":"Epstein","year":"2016","journal-title":"Am J Kidney Dis."},{"key":"10.1111\/ijcp.13052-BIB0009|ijcp13052-cit-0009","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.phrs.2016.09.039","article-title":"Emergency management of severe hyperkalemia: Guideline for best practice and opportunities for the future","volume":"113","author":"Rossignol","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1111\/ijcp.13052-BIB0010|ijcp13052-cit-0010","unstructured":"UK NHS Foundation Trust, Gloucestershire Hospitals Guidelines for the Emergency Treatment of Hyperkalaemia 2011"},{"key":"10.1111\/ijcp.13052-BIB0011|ijcp13052-cit-0011","unstructured":"UK NHS Foundation Trust, Nottingham University Hospitals Guideline for the Management of Acute Hyperkalaemia in Adults 2016"},{"key":"10.1111\/ijcp.13052-BIB0012|ijcp13052-cit-0012","first-page":"43","article-title":"Potassium-Binding Agents for the Clinical Management of Hyperkalemia","volume":"41","author":"Chaitman","year":"2016","journal-title":"Pharmacy and Therapeutics"},{"key":"10.1111\/ijcp.13052-BIB0013|ijcp13052-cit-0013","first-page":"264.e9","article-title":"Gastrointestinal adverse events with sodium polystyrene sulfonate (Kayexalate) use: A systematic review","volume":"126","author":"Harel","journal-title":"The American Journal of Medicine"},{"key":"10.1111\/ijcp.13052-BIB0014|ijcp13052-cit-0014","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1681\/ASN.2010010079","article-title":"Ion-Exchange Resins for the Treatment of Hyperkalemia: Are They Safe and Effective?","volume":"21","author":"Sterns","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ijcp.13052-BIB0015|ijcp13052-cit-0015","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM196101192640303","article-title":"Management of hyperkalemia with a cation-exchange resin","volume":"264","author":"Scherr","year":"1961","journal-title":"N Engl J Med"},{"key":"10.1111\/ijcp.13052-BIB0016|ijcp13052-cit-0016","doi-asserted-by":"crossref","first-page":"805","DOI":"10.4155\/cli.15.48","article-title":"Complications and management of hyperkalemia: Implications for the use of the novel cation exchangers zirconium cyclosilicate and patiromer","volume":"5","author":"Noureddine","year":"2015","journal-title":"Clinical Investigation"},{"key":"10.1111\/ijcp.13052-BIB0017|ijcp13052-cit-0017","doi-asserted-by":"crossref","first-page":"e114686","DOI":"10.1371\/journal.pone.0114686","article-title":"Characterization of Structure and Function of ZS-9, a K+ Selective Ion Trap","volume":"9","author":"Stavros","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1111\/ijcp.13052-BIB0018|ijcp13052-cit-0018","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1411487","article-title":"Sodium zirconium cyclosilicate in hyperkalemia","volume":"372","author":"Packham","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1111\/ijcp.13052-BIB0019|ijcp13052-cit-0019","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/1074248416629549","article-title":"Mechanism of action and pharmacology of patiromer, a nonabsorbed cross-linked polymer that lowers serum potassium concentration in patients with hyperkalemia","volume":"21","author":"Li","year":"2016","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1111\/ijcp.13052-BIB0020|ijcp13052-cit-0020","unstructured":"European Medicines Agency Summary of opinion (initial authorisation) Lokelma http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Summary_of_opinion_-_Initial_authorisation\/human\/004029\/WC500222241.pdf"},{"key":"10.1111\/ijcp.13052-BIB0021|ijcp13052-cit-0021","volume-title":"Veltassa (Patiromer for oral suspension) prescribing information","author":"US Food and Drug Administration","year":"2016"},{"key":"10.1111\/ijcp.13052-BIB0022|ijcp13052-cit-0022","unstructured":"European Medicines Agency European Public Assessment Report (EPAR) Veltassa http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Summary_for_the_public\/human\/004180\/WC500232692.pdf"},{"key":"10.1111\/ijcp.13052-BIB0023|ijcp13052-cit-0023","doi-asserted-by":"crossref","unstructured":"Batterink J Cessford TA Taylor RAI Pharmacological interventions for the acute management of hyperkalaemia in adults Cochrane Database of Systematic Reviews 2015, Issue 10 https:\/\/doi.org\/10.1002\/14651858.CD010344.pub2","DOI":"10.1002\/14651858.CD010344.pub2"},{"key":"10.1111\/ijcp.13052-BIB0024|ijcp13052-cit-0024","first-page":"CD003235","article-title":"Emergency interventions for hyperkalaemia","volume":"2","author":"Mahoney","year":"2005","journal-title":"Cochrane Database of Systematic Reviews (Online)"},{"key":"10.1111\/ijcp.13052-BIB0025|ijcp13052-cit-0025","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/1060028016640794","article-title":"Potassium-Binding Agents to Facilitate Renin-Angiotensin-Aldosterone System Inhibitor Therapy","volume":"50","author":"Schaefer","year":"2016","journal-title":"The Annals of pharmacotherapy"},{"key":"10.1111\/ijcp.13052-BIB0026|ijcp13052-cit-0026","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/phar.1906","article-title":"Systematic review and meta-analysis of patiromer and sodium zirconium cyclosilicate: A new armamentarium for the treatment of hyperkalemia","volume":"37","author":"Meaney","year":"2017","journal-title":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"},{"key":"10.1111\/ijcp.13052-BIB0027|ijcp13052-cit-0027","volume-title":"Systematic Reviews: CRD's guidance for undertaking reviews in health care","author":"Centre for Reviews and Dissemination","year":"2008"},{"key":"10.1111\/ijcp.13052-BIB0028|ijcp13052-cit-0028","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ki.2014.382","article-title":"A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient","volume":"88","author":"Ash","year":"2015","journal-title":"Kidney Int"},{"key":"10.1111\/ijcp.13052-BIB0029|ijcp13052-cit-0029","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jama.2015.7446","article-title":"Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial","volume":"314","author":"Bakris","year":"2015","journal-title":"JAMA"},{"key":"10.1111\/ijcp.13052-BIB0030|ijcp13052-cit-0030","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1001\/jama.2014.15688","article-title":"Effect of sodium zirconium cyclosilicate on potassium lowering for 28\u00a0days among outpatients with hyperkalemia: The HARMONIZE randomized clinical trial","volume":"312","author":"Kosiborod","year":"2014","journal-title":"JAMA - Journal of the American Medical Association"},{"key":"10.1111\/ijcp.13052-BIB0031|ijcp13052-cit-0031","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.2215\/CJN.03640415","article-title":"Randomized clinical trial of sodium polystyrene sulfonate for the treatment of mild hyperkalemia in CKD","volume":"10","author":"Lepage","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/ijcp.13052-BIB0032|ijcp13052-cit-0032","first-page":"455","article-title":"Treatment of hyperkalemia in patients with chronic kidney disease: A comparison of calcium polystyrene sulphonate and sodium polystyrene sulphonate","volume":"26","author":"Nasir","year":"2014","journal-title":"Journal of Ayub Medical College, Abbottabad: JAMC"},{"key":"10.1111\/ijcp.13052-BIB0033|ijcp13052-cit-0033","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/eurheartj\/ehq502","article-title":"Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial","volume":"32","author":"Pitt","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1111\/ijcp.13052-BIB0034|ijcp13052-cit-0034","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1410853","article-title":"Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors","volume":"372","author":"Weir","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1111\/ijcp.13052-BIB0035|ijcp13052-cit-0035","article-title":"Patiromer lowers serum potassium when taken without or with food: Results from an open-label, randomized, parallel-group, phase 4 hyperkalemia study","author":"Pergola","year":"2017","journal-title":"National Kidney Foundation Spring Clinical Meetings"},{"key":"10.1111\/ijcp.13052-BIB0036|ijcp13052-cit-0036","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1681\/ASN.V9101924","article-title":"Effect of single dose resin-cathartic therapy on serum potassium concentration in patients with end-stage renal disease","volume":"9","author":"Gruy-Kapral","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ijcp.13052-BIB0037|ijcp13052-cit-0037","doi-asserted-by":"crossref","first-page":"426","DOI":"10.7326\/0003-4819-110-6-426","article-title":"Nebulized albuterol for acute hyperkalemia in patients on hemodialysis","volume":"110","author":"Allon","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1111\/ijcp.13052-BIB0038|ijcp13052-cit-0038","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/ki.1990.284","article-title":"Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients","volume":"38","author":"Allon","year":"1990","journal-title":"Kidney Int"},{"key":"10.1111\/ijcp.13052-BIB0039|ijcp13052-cit-0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000358836","article-title":"Bolus administration of intravenous glucose in the treatment of hyperkalemia: A randomized controlled trial","volume":"126","author":"Chothia","year":"2014","journal-title":"Nephron - Physiology"},{"key":"10.1111\/ijcp.13052-BIB0040|ijcp13052-cit-0040","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1378\/chest.115.3.617","article-title":"Salbutamol metered-dose inhaler with spacer for hyperkalemia: How fast? How safe?","volume":"115","author":"Mandelberg","year":"1999","journal-title":"Chest"},{"key":"10.1111\/ijcp.13052-BIB0041|ijcp13052-cit-0041","first-page":"503","article-title":"Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: Effect of various therapeutic approaches","volume":"74","author":"Ngugi","year":"1997","journal-title":"East Afr Med J"},{"key":"10.1111\/ijcp.13052-BIB0042|ijcp13052-cit-0042","first-page":"595A","article-title":"Oral Sodium Bicarbonate Reduces Inter-Dialytic Potassium Gain - The BicHD Trial","volume":"27","author":"Kourtellidou","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ijcp.13052-BIB0043|ijcp13052-cit-0043","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/ki.1993.34","article-title":"Effect of insulin-plus-glucose infusion with or without epinephrine on fasting hyperkalemia","volume":"43","author":"Allon","year":"1993","journal-title":"Kidney Int"},{"key":"10.1111\/ijcp.13052-BIB0044|ijcp13052-cit-0044","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0002-9343(88)80086-X","article-title":"Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure","volume":"85","author":"Blumberg","year":"1988","journal-title":"Am J Med"},{"key":"10.1111\/ijcp.13052-BIB0045|ijcp13052-cit-0045","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1159\/000188917","article-title":"Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients","volume":"72","author":"Kim","year":"1996","journal-title":"Nephron"},{"key":"10.1111\/ijcp.13052-BIB0046|ijcp13052-cit-0046","first-page":"A161","article-title":"The combined regimen of bicarbonate and beta2-agonist (salbutamol) in acute therapy of hyperkalemia in hemodialysis patients","volume":"11","author":"Kim","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/ijcp.13052-BIB0047|ijcp13052-cit-0047","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0011-393X(02)80060-1","article-title":"Insulin dose versus rate of potassium decrease in the treatment of hyperkalemia with IV insulin during extracorporeal circulation: An observational study","volume":"63","author":"Kocoglu","year":"2002","journal-title":"Current Therapeutic Research - Clinical and Experimental"},{"key":"10.1111\/ijcp.13052-BIB0048|ijcp13052-cit-0048","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/oxfordjournals.ndt.a091860","article-title":"Treatment of hyperkalaemia in renal failure: Salbutamol v. insulin","volume":"4","author":"Lens","year":"1989","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/ijcp.13052-BIB0049|ijcp13052-cit-0049","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0272-6386(12)80983-8","article-title":"Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure: Comparative study","volume":"23","author":"Liou","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/ijcp.13052-BIB0050|ijcp13052-cit-0050","first-page":"276","article-title":"Intravenous infusion or nebulization of salbutamol for treatment of hyperkalemia in patients with chronic renal failure","volume":"53","author":"Liou","year":"1994","journal-title":"Chinese Medical Journal (Taipei)"},{"key":"10.1111\/ijcp.13052-BIB0051|ijcp13052-cit-0051","first-page":"1082","article-title":"Comparison of aminophylline and insulin-dextrose infusions in acute therapy of hyperkalemia in end-stage renal disease patients","volume":"49","author":"Mahajan","year":"2001","journal-title":"The Journal of the Association of Physicians of India"},{"issue":"2","key":"10.1111\/ijcp.13052-BIB0052|ijcp13052-cit-0052","first-page":"176","article-title":"Treatment of hyperkalemia with salbutamol and insulin","volume":"22","author":"Mushtaq","year":"2006","journal-title":"Pakistan Journal of Medical Sciences"},{"key":"10.1111\/ijcp.13052-BIB0053|ijcp13052-cit-0053","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1053\/j.ajkd.2005.02.016","article-title":"Subcutaneous terbutaline use in CKD to reduce potassium concentrations","volume":"45","author":"Sowinski","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/ijcp.13052-BIB0054|ijcp13052-cit-0054","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(76)91340-4","article-title":"Treatment of attacks in hyperkalaemic familial periodic paralysis by inhalation of salbutamol","volume":"1","author":"Wang","year":"1976","journal-title":"Lancet"},{"key":"10.1111\/ijcp.13052-BIB0055|ijcp13052-cit-0055","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0002-9343(93)90081-Y","article-title":"Glucose modulation of the disposal of an acute potassium load in patients with end-stage renal disease","volume":"94","author":"Allon","year":"1993","journal-title":"Am J Med"},{"key":"10.1111\/ijcp.13052-BIB0056|ijcp13052-cit-0056","doi-asserted-by":"crossref","first-page":"A31","DOI":"10.1053\/j.ajkd.2016.03.056","article-title":"Patiromer Decreases Serum Potassium in Patients on HD","volume":"67","author":"Bushinsky","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/ijcp.13052-BIB0057|ijcp13052-cit-0057","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/ki.2015.270","article-title":"Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia","volume":"88","author":"Bushinsky","year":"2015","journal-title":"Kidney Int"},{"key":"10.1111\/ijcp.13052-BIB0058|ijcp13052-cit-0058","first-page":"i405","article-title":"Calcium polystyrene sulfonate in treating hyperkalemia patients with renal insufficiency","volume":"28","author":"Li","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/ijcp.13052-BIB0059|ijcp13052-cit-0059","doi-asserted-by":"crossref","first-page":"E301","DOI":"10.1016\/S0735-1097(11)60301-X","article-title":"A multicenter study of dose titration of the oral potassium binder RLY5016 to maintain normal serum potassium in patients with heart failure and chronic kidney disease treated with renin-angiotensin-aldosterone inhibitors and\/or \u03b2-blockers","volume":"1","author":"Pitt","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/ijcp.13052-BIB0060|ijcp13052-cit-0060","doi-asserted-by":"crossref","first-page":"379","DOI":"10.5414\/CNP68379","article-title":"Dose-response to a jelly preparation of calcium polystyrene sulfonate in patients with hyperkalemia-changes in serum potassium levels with or without a RAAS inhibitor","volume":"68","author":"Tomino","year":"2007","journal-title":"Clin Nephrol"},{"key":"10.1111\/ijcp.13052-BIB0061|ijcp13052-cit-0061","first-page":"SA","article-title":"Long-term (52-week) efficacy and safety of ZS-9 in the treatment of hyperkalemia: Interim results from a phase 3 open-label, multi-center, multi-dose maintenance study","volume":"26","author":"Tumlin","year":"2015","journal-title":"American Society of Nephrology: J Am Soc Nephrol"},{"key":"10.1111\/ijcp.13052-BIB0062|ijcp13052-cit-0062","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4212\/cjhp.v68i4.1469","article-title":"Effectiveness of sodium polystyrene sulfonate for short-term treatment of hyperkalemia","volume":"68","author":"Batterink","year":"2015","journal-title":"Canadian Journal of Hospital Pharmacy"},{"key":"10.1111\/ijcp.13052-BIB0063|ijcp13052-cit-0063","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/0886022X.2012.745118","article-title":"Potassium binders in hemodialysis patients: A friend or foe?","volume":"35","author":"Chaaban","year":"2013","journal-title":"Ren Fail"},{"key":"10.1111\/ijcp.13052-BIB0064|ijcp13052-cit-0064","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/clc.20987","article-title":"Secondary prevention of hyperkalemia with sodium polystyrene sulfonate in cardiac and kidney patients on renin-angiotensin-aldosterone system inhibition therapy","volume":"35","author":"Chernin","year":"2012","journal-title":"Clin Cardiol"},{"key":"10.1111\/ijcp.13052-BIB0065|ijcp13052-cit-0065","first-page":"PUB457","article-title":"Treatment of hyperkalemia with kayexalate in an academic medical center","volume":"00","author":"Ghosh","year":"2015","journal-title":"American Society of Nephrology: J Am Soc Nephrol"},{"key":"10.1111\/ijcp.13052-BIB0066|ijcp13052-cit-0066","doi-asserted-by":"crossref","first-page":"38","DOI":"10.5414\/CN108628","article-title":"Sodium polystyrene sulfonate for the treatment of acute hyperkalemia: A retrospective study","volume":"85","author":"Hagan","year":"2016","journal-title":"Clin Nephrol"},{"key":"10.1111\/ijcp.13052-BIB0067|ijcp13052-cit-0067","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/jhm.834","article-title":"The use of sodium polystyrene sulfonate in the inpatient management of hyperkalemia","volume":"6","author":"Kessler","year":"2011","journal-title":"J Hosp Med"},{"key":"10.1111\/ijcp.13052-BIB0068|ijcp13052-cit-0068","doi-asserted-by":"crossref","unstructured":"Kim G Yu M Park J Lee C Yeo J Longterm efficacy of oral calcium polystyrene sulfonate for treating hyperkalemia in CKD patients Vienna 53rd ERA-EDTA Congress 2016","DOI":"10.1093\/ndt\/gfw118.04"},{"key":"10.1111\/ijcp.13052-BIB0069|ijcp13052-cit-0069","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/SMJ.0b013e31819e8978","article-title":"Intestinal necrosis due to sodium polystyrene sulfonate (Kayexalate) in sorbitol","volume":"102","author":"McGowan","year":"2009","journal-title":"South Med J"},{"key":"10.1111\/ijcp.13052-BIB0070|ijcp13052-cit-0070","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1177\/001857870403900808","article-title":"Sodium polystyrene sulfonate dosing guidelines for the treatment of adult hyperkalemia","volume":"39","author":"Mikrut","year":"2004","journal-title":"Hospital Pharmacy"},{"issue":"6","key":"10.1111\/ijcp.13052-BIB0071|ijcp13052-cit-0071","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/1060028016641427","article-title":"Evaluation of sodium polystyrene sulfonate dosing strategies in the inpatient management of hyperkalemia","volume":"50","author":"Mistry","year":"2016","journal-title":"The Annals of pharmacotherapy"},{"key":"10.1111\/ijcp.13052-BIB0072|ijcp13052-cit-0072","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2217\/cpr.14.52","article-title":"Management of mild hyperkalemia with sodium polystyrene sulfonate: Is it necessary?","volume":"11","author":"Yousaf","year":"2014","journal-title":"Clinical Practice"},{"key":"10.1111\/ijcp.13052-BIB0073|ijcp13052-cit-0073","doi-asserted-by":"crossref","first-page":"940320","DOI":"10.1155\/2012\/940320","article-title":"To bind or to let loose: Effectiveness of sodium polystyrene sulfonate in decreasing serum potassium","volume":"2012","author":"Sandal","year":"2012","journal-title":"Int J Nephrol"},{"key":"10.1111\/ijcp.13052-BIB0074|ijcp13052-cit-0074","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/ckj\/sfu026","article-title":"Hypoglycemia in the treatment of hyperkalemia with insulin in patients with end-stage renal disease","volume":"7","author":"Apel","year":"2014","journal-title":"Clinical Kidney Journal"},{"key":"10.1111\/ijcp.13052-BIB0075|ijcp13052-cit-0075","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/01.ccm.0000474433.48373.71","article-title":"Association of insulin dose, diabetes, and dialysis with hypoglycemia in treatment of hyperkalemia","volume":"1","author":"LaRue","year":"2015","journal-title":"Crit Care Med"},{"key":"10.1111\/ijcp.13052-BIB0076|ijcp13052-cit-0076","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1177\/1060028015607559","article-title":"Incidence of Hypoglycemia in Patients With Low eGFR Treated With Insulin and Dextrose for Hyperkalemia","volume":"49","author":"Pierce","year":"2015","journal-title":"Ann Pharmacother"},{"key":"10.1111\/ijcp.13052-BIB0077|ijcp13052-cit-0077","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/jhm.977","article-title":"Incidence of hypoglycemia following insulin-based acute stabilization of hyperkalemia treatment","volume":"7","author":"Schafers","year":"2012","journal-title":"J Hosp Med"},{"key":"10.1111\/ijcp.13052-BIB0078|ijcp13052-cit-0078","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.resuscitation.2015.09.384","article-title":"The effects of calcium and sodium bicarbonate on severe hyperkalaemia during cardiopulmonary resuscitation: A retrospective cohort study of adult in-hospital cardiac arrest","volume":"98","author":"Wang","year":"2016","journal-title":"Resuscitation"},{"key":"10.1111\/ijcp.13052-BIB0079|ijcp13052-cit-0079","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/jhm.2545","article-title":"Weight-based insulin dosing for acute hyperkalemia results in less hypoglycemia","volume":"11","author":"Wheeler","year":"2016","journal-title":"J Hosp Med"},{"key":"10.1111\/ijcp.13052-BIB0080|ijcp13052-cit-0080","first-page":"A605","article-title":"Risk factors for hypoglycemia after insulin-based acute hyperkalemia treatment","volume":"64","author":"Wu","year":"2015","journal-title":"Diabetes"},{"key":"10.1111\/ijcp.13052-BIB0081|ijcp13052-cit-0081","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/j.jvca.2009.01.032","article-title":"Insulin Therapy in Divided Doses Coupled With Blood Transfusion Versus Large Bolus Doses in Patients at High Risk for Hyperkalemia During Liver Transplantation","volume":"24","author":"Xia","year":"2010","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1111\/ijcp.13052-BIB0082|ijcp13052-cit-0082","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1080\/00015458.2014.11681051","article-title":"The effectiveness and impact of 10 gram glucose and 10 units insulin in treating hyperkalemia during living donor liver transplantation","volume":"114","author":"Yang","year":"2014","journal-title":"Acta Chir Belg"},{"key":"10.1111\/ijcp.13052-BIB0083|ijcp13052-cit-0083","doi-asserted-by":"crossref","first-page":"e0172961","DOI":"10.1371\/journal.pone.0172961","article-title":"Hypoglycemia following intravenous insulin plus glucose for hyperkalemia in patients with impaired renal function","volume":"12","author":"Coca","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1111\/ijcp.13052-BIB0084|ijcp13052-cit-0084","first-page":"S201","article-title":"Hypoglycemia is a common complication of insulin administration for treatment of hyperkalemia in the ed","volume":"23","author":"Driver","year":"2016","journal-title":"Acad Emerg Med"},{"key":"10.1111\/ijcp.13052-BIB0085|ijcp13052-cit-0085","first-page":"SA","article-title":"Wide range in variation in serum potassium in hyperkalemic patients with CKD, response to a fixed 60 mEq potassium diet","volume":"25","author":"Bushinsky","year":"2014","journal-title":"American Society of Nephrology: J Am Soc Nephrol"},{"key":"10.1111\/ijcp.13052-BIB0086|ijcp13052-cit-0086","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0167-4943(01)00214-X","article-title":"Spironolactone therapy in older patients - The impact of renal dysfunction","volume":"35","author":"Butler","year":"2002","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1111\/ijcp.13052-BIB0087|ijcp13052-cit-0087","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000013599","article-title":"Predictors of the development of hyperkalemia in patients using angiotensin-converting enzyme inhibitors","volume":"20","author":"Ahuja","year":"2000","journal-title":"Am J Nephrol"},{"key":"10.1111\/ijcp.13052-BIB0088|ijcp13052-cit-0088","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1177\/1470320313507122","article-title":"The effect of renin-angiotensin system blockade on renal protection in chronic kidney disease patients with hyperkalemia","volume":"15","author":"Lee","year":"2014","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1111\/ijcp.13052-BIB0089|ijcp13052-cit-0089","first-page":"P106","article-title":"Pro-active individualised dietary modification reduces the prevalence of hyperkalaemia in patients with advanced CKD","author":"MacLaughlin","year":"2015","journal-title":"British Renal Society Conference 2015. Leeds"},{"key":"10.1111\/ijcp.13052-BIB0090|ijcp13052-cit-0090","unstructured":"US Food and Drug Administration Kayexalate \u00ae . Sodium Polystyrene Sulfonate, USP. Cation-Exchange Resin https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/011287s023lbl.pdf 2010"},{"key":"10.1111\/ijcp.13052-BIB0091|ijcp13052-cit-0091","unstructured":"eMC Resonium A (Sodium Polystyrene Sulfonate) Summary of Product Characteristics https:\/\/www.medicines.org.uk\/emc\/medicine\/6988"},{"key":"10.1111\/ijcp.13052-BIB0092|ijcp13052-cit-0092","unstructured":"eMC Calcium Resonium (Calcium Polystyrene Sulfonate) Summary of Product Characteristics https:\/\/www.medicines.org.uk\/emc\/medicine\/6739"},{"key":"10.1111\/ijcp.13052-BIB0093|ijcp13052-cit-0093","unstructured":"WHO Collaborating Centre for Drug Statistics and Methodology Defined Daily Dose for V03AE01 polystyrene sulfonate https:\/\/www.whocc.no\/atc_ddd_index\/?code=V03AE01&showdescription=yes"},{"key":"10.1111\/ijcp.13052-BIB0094|ijcp13052-cit-0094","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1056\/NEJMp1210007","article-title":"Reform, Regulation, and Pharmaceuticals - The Kefauver-Harris Amendments at 50","volume":"367","author":"Greene","year":"2012","journal-title":"The New England journal of medicine"},{"key":"10.1111\/ijcp.13052-BIB0095|ijcp13052-cit-0095","unstructured":"European Commission Directive 65\/65\/EEC 1965 http:\/\/eur-lex.europa.eu\/LexUriServ\/LexUriServ.do?uri=CELEX:31965L0065:EN:HTML"},{"key":"10.1111\/ijcp.13052-BIB0096|ijcp13052-cit-0096","unstructured":"European Commission Public Health 50\u00a0years Eu Pharmaceutical Regulation Milestones http:\/\/ec.europa.eu\/health\/human-use\/50years\/docs\/50years_pharma_timeline_v3.pdf 2015"},{"issue":"8","key":"10.1111\/ijcp.13052-BIB0097|ijcp13052-cit-0097","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/phar.1797","article-title":"Sodium Zirconium Cyclosilicate (ZS-9): A Novel Agent for the Treatment of Hyperkalemia","volume":"36","author":"Linder","year":"2016","journal-title":"Pharmacotherapy"},{"key":"10.1111\/ijcp.13052-BIB0098|ijcp13052-cit-0098","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1093\/ndt\/gfx146.SP318","article-title":"SP318 Healthcare resource utilization associated with elevated potassium in patients with chronic kidney disease. (Poster)","volume":"32","author":"Thomsen","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/ijcp.13052-BIB0099|ijcp13052-cit-0099","doi-asserted-by":"crossref","unstructured":"Thomsen RW Nicolaisen SK Kim K Palaka E Sorenson HT Healthcare resource utilization associated with elevated potassium levels in patients with congestive heart failure. To be presented at the European Society of Cardiology congress, Barcelona 2017. (Poster) 2017","DOI":"10.1093\/eurheartj\/ehx501.P593"},{"key":"10.1111\/ijcp.13052-BIB0100|ijcp13052-cit-0100","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1093\/ndt\/gfx170.MP380","article-title":"MP380 Clincal outcomes associated with hyperkalemia in adults in the UK. (Poster)","volume":"32","author":"Horne","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/ijcp.13052-BIB0101|ijcp13052-cit-0101","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2215\/CJN.01730215","article-title":"Association between Serum Potassium and Outcomes in Patients with Reduced Kidney Function","volume":"11","author":"Luo","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/ijcp.13052-BIB0102|ijcp13052-cit-0102","first-page":"2","article-title":"New questions on old drug for hyperkalemia","volume":"00","author":"Timothy","year":"2010","journal-title":"Kidney News"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijcp.13052","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ijcp.13052\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T13:58:24Z","timestamp":1660399104000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijcp.13052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,30]]},"references-count":102,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"URL":"https:\/\/doi.org\/10.1111\/ijcp.13052","archive":["Portico"],"relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1,30]]}}}